Emory University Opposition, Lamivudine (3 Tc) , (Ep90301335)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
- 
              Indian Network of People Living with HIV/AIDS (INP+) and Manipur Network of Positive People (MNP+) opposition, zidovudine/lamivudine (AZT/3TC) , (2044/CAL/1997)Countries: India Date: 2006 
- 
              AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Dolutegravir/Abacavir/Lamivudine , (TH1201003753)Countries: Thailand Date: 2017 
- 
              LEK Pharmaceuticals opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)Countries: Europe (EPO) Date: 2016 
- 
              Page White & Farrer opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)Countries: Europe (EPO) Date: 2016 
- 
              ter Meer Steinmeister & Partner opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)Countries: Europe (EPO) Date: 2016 
- 
              Apotex Corp opposition, Zidovudine/Lamivudine/Abacavir, (US6417191)Countries: United States of America Date: 2015 
- 
              ABIA/GTPI opposition, Dolutegravir/Lamivudine, (WO2019074826 BR112020006783-0 )Countries: Brazil Date: 2024 
- 
              Initiative for Medicines, Access & Knowledge (I-Mak) opposition, lopinavir/ritonavir (LPV/r) , (339/MUMNP/2006)Countries: India Date: 2007 
- 
              Cipla Ltd. opposition, lopinavir/ritonavir (LPV/r) , (726/MUMNP/2009 (Divisional of 339/MUMNP/2006))Countries: India Date: 2010 
- 
              Matrix Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (2474/DELNP/2009 (Divisional of 339/MUMNP/2006))Countries: India Date: 2010